BioSpace News Archive

Synthetic Biology Market Size USD 55,372.2 Mn by 2030 With a CAGR of 19.7%

Latest Study on “Synthetic Biology Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

October 27, 2022
·
6 min read
Bio NC

Thermo Fisher Scientific to Expand Clinical Research Laboratory in Kentucky

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to invest $59 million to significantly expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients.

October 27, 2022
·
3 min read
Business

LeMaitre Q3 2022 Financial Results

LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2022 results, announced a $0.125/share quarterly dividend and provided guidance.

October 27, 2022
·
13 min read
BiVACOR® Awarded Grant to Advance Development of External Controller for its Total Artificial Heart

The grant is matched by in-kind support bringing approximately AUD$2.2 million in funding for BiVACOR’s clinical advancement.

October 27, 2022
·
4 min read
Business

Dyadic to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI) today announced that it will report its financial results for the third quarter 2022 and host a corporate update conference call on Thursday, November 10, 2022.

October 27, 2022
·
3 min read
Business

Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022

Geron Corporation (Nasdaq: GERN) today announced that it will release its third quarter 2022 financial results before the market opens on Thursday, November 3, 2022 via press release, which will be available on the Company’s website at www.geron.com/investors.

October 27, 2022
·
1 min read
Business

Alvotech to Report First Nine Months Financial Results on November 15, 2022 and Host Business Update Conference Call at 8:00 am ET on November 16, 2022

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first nine months of 2022, after U.S. markets close on Tuesday, November 15, 2022.

October 27, 2022
·
2 min read
Pharm Country

Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022

Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders.

October 27, 2022
·
5 min read
BioForest

Aurion Biotech Wins Prestigious Prix Galien Startup Award

Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, announced it has won the prestigious Prix Galien Award for Best Startup in Biotech / Pharma.

October 27, 2022
·
4 min read
Drug Development

Sciwind Biosciences Announces Positive Interim Results from Ongoing Phase 2b Clinical Trial of XW003 (Ecnoglutide) in Patients with Obesity

Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today positive results from an interim analysis of the on-going Phase 2b clinical trial of XW003 (ecnoglutide) in patients with obesity.

October 27, 2022
·
4 min read